Overview of Nervikan

Nervikan is a combination phytotherapeutic agent used to provide calming support for nervous excitability and restlessness. This preparation is generally classified as a traditional herbal medicinal product, where its efficacy is supported by long-standing experience rather than primarily clinical trials.

Property	Description
Active ingredient	Valerian extract (Valeriana officinalis), Melissa extract (Melissa officinalis)
Form	Oral dosage form (Tablet or Capsule)
Pharmacological class	Phytosedative / Mild Anxiolytic agent
Common use	Relief of mild stress symptoms and aid to sleep
Origin	Natural origin (Herbal)

1. Defining Nervikan: A Polyherbal Sedative Agent

Nervikan is a fixed combination product of natural origin, supplied as an oral dosage form. Its primary pharmacological class is that of a phytosedative and mild anxiolytic agent. Valerian root and Melissa leaf are herbal substances traditionally used for the relief of mild mental stress and to aid sleep. This means the preparation is recognized for its general ability to promote a state of calmness and support the initiation of rest. The oral route of administration is necessary for the systemic activity of the active components.

2. Active Components: Valerian and Melissa Extracts

The active ingredients are specific extracts of Valerian root and Melissa leaf, utilized as a polyherbal formulation. The Valerian extract is known to contain sesquiterpenes like valerenic acid, compounds which are thought to promote relaxation through interaction with neurotransmitter systems. Valerian is one of the most commonly used herbal products for sleep problems. This combination distinguishes Nervikan from single-ingredient Valerian products, aiming for synergistic action where Melissa extract complements the sedative core with a mild tension relieving effect.

3. General Purpose: Calming Support for Nervous Restlessness

The general purpose of Nervikan is to provide support for symptoms associated with nervousness and mental stress, such as when restlessness interferes with the ability to unwind in the evening. The combined extracts work by gently modulating certain neurotransmitter pathways to enhance the body's natural processes of inhibition and tranquility. This physiological action is intended to support the body in achieving relaxation and facilitating the onset of restful sleep, providing a recognized herbal-based approach for mild stress symptoms.

Regulatory References

What side effects are possible with Nervikan?

Possible Side Effects and Safety Information

The safety profile for this traditional phytotherapeutic agent is defined by documented adverse reactions and official regulatory constraints. The adverse effects associated with Nervikan (Valerian and Melissa extracts) are primarily classified by regulatory authorities as having a frequency not known, indicating that the available data do not permit a reliable estimate of how often they occur.

Documented Adverse Reactions

Adverse events are generally categorized within the following System-Organ Classes (SOC):

System-Organ Class	Documented Reactions
Gastrointestinal Disorders	Nausea, abdominal cramps, vomiting, and diarrhea.
Nervous System Disorders	Dizziness and headache.
Psychiatric Disorders	Nightmares or vivid dreams.

Safety Considerations and Constraints

Special Population Restrictions: Use is officially not recommended for children and adolescents below 12 years of age, and during pregnancy and lactation, due to the absence of sufficient safety data.

Serious Adverse Events: The regulatory profile acknowledges the potential for a very rare, but clinically significant adverse reaction: liver injury, associated with the Valerian component.

High-Level Constraints: Due to its sedative properties, the medicine may impair the ability to drive or operate machinery, and this is included as a general safety restriction. Furthermore, an explicit caution is documented regarding the potential for additive sedative effects when used with alcohol or other central nervous system depressants, as well as a contraindication for individuals with known hypersensitivity to the extracts.

Overdose and Emergency Response

Overdose and When to Seek Help

Information in this section is derived strictly from the official overdose guidance provided in government regulatory documents (e.g., FDA, EMA).

Documented Overdose Manifestations

An overdose of Nervikan can lead to signs of Central Nervous System (CNS) depression. Documented manifestations commonly include profound drowsiness, somnolence, slurred speech, and impaired physical coordination (ataxia). In cases of significant overexposure, the progression can lead to more serious CNS impairment.

Life-Threatening Outcomes

The most serious outcome noted in regulatory documents is respiratory depression, a life-threatening condition characterized by slow or shallow breathing. Severe overdose can result in stupor or a comatose state. The risk and severity of these outcomes are officially noted to be substantially increased when Nervikan is taken with other depressant substances, particularly alcohol.

Emergency Action

Immediate medical attention is required for any suspected overdose. The official guidance states that emergency care must be sought for any person exhibiting signs of respiratory difficulty or significant loss of consciousness. Medical management typically involves general supportive care, maintenance of the airway, and symptomatic treatment of observed effects, following established medical protocols.

Therapeutic Uses of Nervikan

What Nervikan Treats: Main Uses and Benefits

Nervikan may be part of symptomatic management and is commonly used to provide general support in managing symptoms associated with nervous overstimulation and mild distress. The preparation contains extracts of Valerian root and Melissa leaf (Lemon Balm), associated with calming properties. The use of Valerian is established for the relief of mild nervous tension and to aid sleep. The core therapeutic application is relevant for symptom clusters related to stress and sleep interference.

The preparation may be part of symptomatic management in situations involving symptoms of nervous excitability, feelings of inner agitation, and pre-sleep nervousness that interfere with the ability to initiate rest. It is commonly used for episodic difficulty falling asleep due to stress, which are conditions characterized by periods of heightened symptoms. This supportive relief helps ease the overall symptom burden, and may assist with maintaining comfort during temporary periods of increased discomfort.

“This traditional preparation supports patients seeking symptomatic relief from nervous tension that impedes the ability to relax.”

Quick Fact: Supportive Management for Nervous Tension and Sleep Disturbances Nervikan is relevant when supportive symptom management is appropriate for mild stress symptoms and when pre-sleep restlessness interferes with successful transition into sleep.

Regulatory References

European Union herbal monograph on Valeriana officinalis L., radix

Eligibility and Restrictions for Use

The eligibility profile for Nervikan, a traditional herbal medicine containing Valerian root and Melissa leaf extracts, is strictly defined by regulatory authorities based on age, known allergies, and the availability of safety data in specific populations.

Approved and Non-Eligible Users

The preparation is suitable for use by Adults and Adolescents from 12 years of age onward. Official regulatory labeling dictates that use is prohibited or not recommended in children under 12 years due to insufficient data on efficacy and safety in that age group.

Contraindications and Restrictions

Nervikan is formally contraindicated and must not be used by patients who have a known hypersensitivity (allergy) to the active substances (Valerian or Melissa extract) or to any of the non-active components (excipients) in the formulation.

Due to the absence of sufficient data regarding safety, the medicine is not recommended for use by women who are pregnant or breastfeeding (lactating).

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official Regulatory Profile

The interaction profile for Nervikan, which contains Valerian and Melissa extracts, is primarily defined by the risk of Pharmacodynamic Potentiation as noted in government regulatory monographs. This means the preparation may increase the effects of other substances that act on the central nervous system (CNS).

Interacting Substance Categories and Restrictions:

Substance Category	Interaction Classification	Official Regulatory Constraint
Synthetic Sedative Medicinal Products	Pharmacodynamic Potentiation	Combination is not recommended due to the risk of an additive sedative effect.
Alcohol (Ethanol)	Pharmacodynamic Potentiation	Consumption is restricted or advised against due to enhanced CNS depressant effect.
Other Sedative Herbal Products	Pharmacodynamic Potentiation	Co-use is advised against due to the potential for enhanced sedative effects.

Official regulatory assessments confirm that clinically relevant pharmacokinetic interactions involving major Cytochrome P450 (CYP) enzymes—including CYP 2D6, CYP 3A4/5, and CYP 1A2—have not been established as mandatory label restrictions for the final product. No formal absolute contraindications or specific dose-timing separation requirements are specified in the official regulatory documentation. The constraints focus exclusively on avoiding combinations that increase the overall level of sedation.

Mechanism of Action

How Nervikan Works

Modulating the Central Inhibitory System

The primary mechanism involves Positive Allosteric Modulation (PAM) of the GABA A receptor complex in the brain by valerenic acid from Valerian. This interaction enhances the effect of the primary inhibitory neurotransmitter, GABA, causing a greater influx of chloride ions ( Cl^-) into the neuron. This cellular process leads to widespread reduced neuronal excitability and contributes to a state of diminished central nervous system activity.

Multi-Target Action and Pathway Synergy

Nervikan employs multi-target engagement by combining the GABA A modulation from Valerian with the complementary activity of Melissa extract. Melissa contributes a milder GABA A PAM effect and acts as an antagonist on cholinergic receptors ( M1). This synergy simultaneously increases the inhibitory signal and reduces excitatory input, enhancing the overall modulation of neuronal activity.

Mechanistic Constraints on Potency

The active compounds function as low-potency, broad-spectrum modulators, possessing lower receptor affinity compared to selective synthetic agents. This non-specific, mild level of pathway modulation constrains the extent of the physiological shift. This mild mechanism can be functionally overridden by significant acute excitatory stimuli, placing a natural constraint on the extent of the resulting physiological dampening.

Dosage and Administration Information

Nervikan is a phytotherapeutic preparation intended for oral use in the form of a coated solid dosage form. This administration route is necessary for the systemic activity of the Valerian and Melissa extracts.

The standard administration guidelines outline distinct dosage patterns based on the intended use. For supporting mild nervous tension, the regimen typically involves 1 tablet taken up to three times daily. When used specifically to aid sleep, a single dose of 1 to 2 tablets is administered in the evening. The dose for sleep is typically taken approximately 30 to 60 minutes before going to bed.

For proper intake, the coated tablet must be swallowed whole with sufficient liquid, rather than being chewed or crushed, and administration is generally recommended to occur after meals. Because of its gradual onset of efficacy, the product is not designed for acute intervention; it is generally recommended for continued use over 2 to 4 weeks to allow the optimal effect to develop.

Dosage is standardized for adults and adolescents 12 years of age and older. Use in children under 12 years is not recommended, as the necessary safety and efficacy data for this age group have not been established.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Nervikan

Evidence for Use in Mild Nervous Tension and Stress Symptoms

Studies conducted during periods of increased symptom activity have examined the effects of the active components of Nervikan (Valerian and Melissa extracts) on outcomes related to the experience of mild nervous tension and agitation. Research in this area primarily involves short-term Randomized Controlled Trials (RCTs) and Systematic Reviews that were evaluated in populations of healthy adults and individuals reporting fluctuating or unstable symptoms of non-clinical stress. These studies monitored patient-reported outcomes describing perceived discomfort and used research methods exploring physiological strain or stress, such as measures of heart rate and blood pressure changes when exposed to laboratory-induced stress.

Research so far evidence provides context on symptom patterns by describing patterns observed in the studies monitoring self-reported feelings of tension. However, the findings related to objective physiological outcomes (like heart rate changes) have been mixed across different studies, and the results apply only to the populations studied.

Evidence for Use in Sleep Disturbances

The research base for using Nervikan's components to aid sleep mainly consists of Randomized Controlled Trials (RCTs) against placebo and Meta-analyses. These studies were studied for individuals with episodic difficulty falling asleep and those reporting generally poor sleep quality. Research examined patient-reported outcomes such as measurements of the time it took to fall asleep (sleep latency) and overall subjective sleep quality and duration. Some research also explored objective outcomes using monitoring equipment like polysomnography (PSG).

The findings describe patterns observed in the studies monitoring patient-reported experiences where patients reported measurements of the time it took to fall asleep and in their overall perceived discomfort with sleep quality. However, the objective data collected using PSG equipment has been mixed and often show patterns related to no consistent difference compared to placebo.

Long-Term Research and Study Duration

Most clinical research conducted on Valerian and Melissa extracts studies monitored responses over defined time intervals. These follow-up durations were limited to generally short periods, typically ranging from a few weeks (2 to 8 weeks) of continuous daily use. This means that long-term effects are not fully established, and there is limited information for long-term outcomes beyond the initial evaluation period. The evidence provides context on symptom patterns, but the data does not offer extensive insight into the durability of the response.

What Is Still Uncertain About the Research Base

A significant area of uncertainty involves the inconsistency between subjective and objective outcomes in sleep research, as patient-reported observations often contrast with the lack of consistent findings from objective measurements. Additionally, the comparative evidence is lacking to definitively show how the Valerian and Melissa extracts work together versus when they are taken individually. Finally, evidence quality varies across studies due to a wide range of different extract preparations and doses used, which complicates the synthesis of a consistent scientific picture.

Key Studies & References Valerian: Usefulness and Safety | NCCIH

Frequently Asked Questions (FAQ)

Common questions about Nervikan (FAQ)

Q: Is Nervikan a pain reliever or is it for something else?

A: Nervikan is officially classified as a central nervous system hypnotic and sedative medicine. It is indicated for the symptomatic treatment of temporary and mild states of nervousness and occasional difficulty falling asleep that are of nervous origin. It is not classified as a pain reliever.

Q: Can Nervikan make you feel drowsy or sleepy?

A: Official product information indicates that this medication may affect your ability to drive or use machinery. This warning suggests a potential for reduced alertness or drowsiness. This effect is consistent with its classification as a sedative used to help with sleep.

Q: Can older adults use Nervikan safely?

A: According to official guidance, the recommended dosage for older adults is the same as for other adults (12 years of age and older). However, regulatory documents consistently state that patients generally need to inform their doctor of any existing health conditions or other medicines being taken.

Q: Does Nervikan interact with common foods or drinks, like coffee or grapefruit juice?

A: Official warnings describe the importance of avoiding alcoholic beverages while using Nervikan, as alcohol can increase the product's sedative effects and cause greater drowsiness. Specific information regarding interactions with common items like coffee or grapefruit juice is generally not detailed in the public patient leaflets.

Q: Is Nervikan meant to be used for a long time or just for a short period?

A: Official guidance describes that use for more than 14 consecutive days is not recommended without consulting a doctor. If the original condition persists or worsens after two weeks of continuous use, consulting a healthcare professional is noted as necessary. The product is intended for short-term symptomatic relief.

Q: What should I do if the medicine does not seem to be working?

A: If the condition worsens or does not improve after 14 days of continuous use, regulatory guidance states that a healthcare professional should be consulted. This is because the optimal effect is expected to develop within a couple of weeks, and a lack of response may indicate a need for reassessment.

Q: Is Nervikan used for chronic conditions or acute problems?

A: The official indication is for the symptomatic treatment of temporary and mild states of nervousness and occasional difficulty falling asleep. This indicates the product is intended for short-term or temporary issues rather than chronic, long-term conditions.

Q: What are the most common reasons people are told not to use Nervikan?

A: The main contraindication described in the official documents is a known allergy or hypersensitivity to the active ingredients (Valerian root, Melissa leaves) or any of the other components (excipients) in the medication. Regulatory information also restricts its use to adults and adolescents 12 years of age and older.

Q: Does Nervikan affect my ability to concentrate or drive?

A: Official information states explicitly that this product may affect your ability to drive or use machines. Official warnings describe the importance of considering the potential for reduced alertness when engaging in activities that require full concentration.

Q: Is Nervikan considered a type of antidepressant?

A: No, Nervikan is officially classified as a central nervous system hypnotic and sedative medicine. Its intended use is for the symptomatic treatment of mild nervousness and difficulty sleeping, which is a different classification than an antidepressant.

Q: What does the research say about Nervikan's long-term use?

A: Official guidance states that use for more than 14 consecutive days is generally not recommended without consulting a doctor. This recommendation is based on the lack of sufficient long-term safety and efficacy data in regulatory documents beyond that time frame.

Q: Is Nervikan safe to use while breastfeeding is being considered?

A: The use of Nervikan is not recommended during pregnancy or breastfeeding. This stance is taken by regulatory bodies due to a lack of sufficient and complete data to confirm its safety in these specific situations.

Q: What if I take an occasional alcoholic drink while using Nervikan?

A: Regulatory warnings associated with the active ingredient describe the importance of avoiding alcoholic beverages. Combining alcohol with Nervikan can increase the risk of drowsiness and enhance the product's sedative effects.

Q: Is it normal to feel a slight headache after starting Nervikan?

A: Regulatory reports for the active ingredient Valerian have noted potential side effects that can include headache. However, the official Nervikan product leaflet may not specify the exact frequency of this occurrence.

Q: Does Nervikan contain any common allergens like gluten or lactose?

A: Regulatory product information confirms that the medication contains sucrose as a non-active ingredient and is essentially sodium-free. Official information indicates that patients with specific allergies generally need to consult the full list of non-active ingredients (excipients) in the official leaflet.

Q: Are there any specific activities or sports I should avoid while using Nervikan?

A: Official information advises that the product may affect your ability to drive or use machines. Official warnings state that activities requiring full alertness and coordination are generally advised to be avoided until the patient knows how Nervikan affects them.

Q: What are the signs that a side effect from Nervikan might be serious?

A: While specific serious side effects for Nervikan are not always listed in the patient leaflet, regulatory data for its active ingredient (Valerian) has noted signs that may require immediate attention, such as persistent nausea/vomiting, yellowing of the skin or eyes, or dark urine. Regulatory documents indicate that these signs generally require immediate reporting.

Q: Are there certain health conditions that prevent someone from using Nervikan?

A: The product is officially contraindicated (should not be used) if a person has a known allergy or hypersensitivity to the active ingredients or any of the non-active components in the tablet.

Q: If I am taking multiple medicines, how do I check for Nervikan interactions?

A: The official document states that informing a doctor or pharmacist of all medicines being taken is required. This professional guidance is necessary to check for potential interactions before starting Nervikan.

Q: Is Nervikan known to cause stomach upset or nausea?

A: Gastrointestinal symptoms, including nausea and abdominal cramps, are known to potentially occur as side effects. Regulatory documents state that the exact frequency of these side effects is not known.

Q: Does Nervikan affect fertility?

A: Official product information states that no data is available regarding the influence of Nervikan on human fertility.

How should Nervikan be stored and disposed of?

How to Store and Dispose of Nervikán

Nervikán must be stored according to specific regulatory requirements to maintain the stability of its herbal extracts. The medication must be kept out of the sight and reach of children for safety.

Storage Requirements

Item	Requirement
Temperature	Store below 30°C.
Environment	Must be kept in a dry place.
Stability	Do not use after the expiration date shown on the box.

Disposal Instructions

To protect the environment, Nervikán must not be disposed of through wastewater or household waste.

Unused or expired product and its packaging must be returned to an authorized pharmaceutical waste collection point (such as a SIGRE point in a pharmacy) for proper handling and disposal.

Nervikan